Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 9 studies | 25% ± 7% | |
peripheral blood | 4 studies | 19% ± 3% | |
placenta | 4 studies | 24% ± 4% | |
prostate | 4 studies | 39% ± 15% | |
breast | 4 studies | 22% ± 5% | |
intestine | 4 studies | 21% ± 6% | |
kidney | 3 studies | 17% ± 2% | |
uterus | 3 studies | 24% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 2429.25 | 359 / 359 | 100% | 33.23 | 286 / 286 |
lung | 100% | 3300.54 | 578 / 578 | 100% | 37.92 | 1153 / 1155 |
intestine | 100% | 2694.16 | 966 / 966 | 100% | 37.24 | 526 / 527 |
prostate | 100% | 3818.29 | 245 / 245 | 100% | 29.30 | 501 / 502 |
ovary | 100% | 2835.12 | 180 / 180 | 100% | 30.82 | 429 / 430 |
breast | 100% | 3284.19 | 459 / 459 | 100% | 34.29 | 1114 / 1118 |
bladder | 100% | 3130.62 | 21 / 21 | 100% | 42.09 | 502 / 504 |
skin | 100% | 3979.10 | 1809 / 1809 | 100% | 29.43 | 470 / 472 |
uterus | 100% | 2780.28 | 170 / 170 | 100% | 37.50 | 457 / 459 |
esophagus | 100% | 2357.16 | 1444 / 1445 | 99% | 34.32 | 182 / 183 |
thymus | 100% | 2522.99 | 653 / 653 | 99% | 36.23 | 600 / 605 |
kidney | 100% | 3037.48 | 89 / 89 | 96% | 26.98 | 866 / 901 |
pancreas | 97% | 1236.84 | 318 / 328 | 94% | 30.76 | 168 / 178 |
liver | 100% | 2178.82 | 225 / 226 | 85% | 15.04 | 346 / 406 |
adrenal gland | 100% | 2338.15 | 258 / 258 | 35% | 5.55 | 81 / 230 |
brain | 52% | 472.20 | 1370 / 2642 | 59% | 10.62 | 419 / 705 |
adipose | 100% | 2848.75 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 2514.37 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 28.41 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.49 | 1 / 1 |
blood vessel | 100% | 2490.07 | 1333 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 29.70 | 79 / 80 |
heart | 85% | 1067.72 | 735 / 861 | 0% | 0 | 0 / 0 |
muscle | 82% | 1192.52 | 658 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 79% | 15.93 | 23 / 29 |
peripheral blood | 79% | 779.03 | 736 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0071363 | Biological process | cellular response to growth factor stimulus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0070410 | Molecular function | co-SMAD binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
Gene name | TGIF1 |
Protein name | Homeobox protein TGIF1 (5'-TG-3'-interacting factor 1) TGFB induced factor homeobox 1 |
Synonyms | TGIF |
Description | FUNCTION: Binds to a retinoid X receptor (RXR) responsive element from the cellular retinol-binding protein II promoter (CRBPII-RXRE). Inhibits the 9-cis-retinoic acid-dependent RXR alpha transcription activation of the retinoic acid responsive element. Active transcriptional corepressor of SMAD2. Links the nodal signaling pathway to the bifurcation of the forebrain and the establishment of ventral midline structures. May participate in the transmission of nuclear signals during development and in the adult, as illustrated by the down-modulation of the RXR alpha activities. |
Accessions | F8VVS9 ENST00000549253.5 F8VUY0 ENST00000345133.9 [Q15583-4] ENST00000552383.5 ENST00000577543.5 ENST00000551333.1 ENST00000549468.5 ENST00000549780.5 ENST00000401449.5 [Q15583-4] ENST00000546979.5 ENST00000551402.1 F8VX54 ENST00000400167.6 [Q15583-4] F8VYL4 J3KS32 ENST00000551541.5 [Q15583-4] ENST00000343820.10 [Q15583-2] F8VZH2 F8VWK5 ENST00000472042.1 [Q15583-4] ENST00000618001.4 [Q15583-3] ENST00000405385.7 [Q15583-4] ENST00000549546.5 ENST00000407501.6 [Q15583-2] Q15583 ENST00000548489.6 [Q15583-4] ENST00000550958.5 F8VW34 ENST00000330513.10 [Q15583-4] F8VXG3 F8W1J9 |